These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10706177

  • 21. Vancomycin functionalized WO3 thin film-based impedance sensor for efficient capture and highly selective detection of Gram-positive bacteria.
    Singh S, Moudgil A, Mishra N, Das S, Mishra P.
    Biosens Bioelectron; 2019 Jul 01; 136():23-30. PubMed ID: 31029006
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Identification and susceptibility testing of microorganism by direct inoculation from positive blood culture bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and effective.
    Romero-Gómez MP, Gómez-Gil R, Paño-Pardo JR, Mingorance J.
    J Infect; 2012 Dec 01; 65(6):513-20. PubMed ID: 22940580
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Longitudinal surveillance on antibiogram of important Gram-positive pathogens in Southern China, 2001 to 2015.
    Xu Z, Xie J, Peters BM, Li B, Li L, Yu G, Shirtliff ME.
    Microb Pathog; 2017 Feb 01; 103():80-86. PubMed ID: 27894963
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection].
    Ji M, Lee M, Noh S, Kim MN.
    Korean J Lab Med; 2010 Dec 01; 30(6):637-46. PubMed ID: 21157151
    [Abstract] [Full Text] [Related]

  • 27. Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide.
    Jones RN, Turnidge JD, Moeck G, Arhin FF, Mendes RE.
    Antimicrob Agents Chemother; 2015 Apr 01; 59(4):2405-9. PubMed ID: 25666152
    [Abstract] [Full Text] [Related]

  • 28. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW, Woerther PL, Soussy CJ, Fines-Guyon M, Dowzicky MJ.
    Antimicrob Resist Infect Control; 2018 Apr 01; 7():68. PubMed ID: 29876099
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Blood culture gram stain, acridine orange stain and direct sensitivity-based antimicrobial therapy of bloodstream infection in patients with trauma.
    Behera B, Mathur P, Gupta B.
    Indian J Med Microbiol; 2010 Apr 01; 28(2):138-42. PubMed ID: 20404460
    [Abstract] [Full Text] [Related]

  • 32. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH.
    Antimicrob Agents Chemother; 2007 Oct 01; 51(10):3726-30. PubMed ID: 17646414
    [Abstract] [Full Text] [Related]

  • 33. [Analysis on the susceptibility of fusidic acid for common gram positive bacteria].
    Liu C, Wang ZQ, Li R, Sun XG.
    Zhonghua Yan Ke Za Zhi; 2009 May 01; 45(5):452-5. PubMed ID: 19576070
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Middle Eastern Study Group.
    Shibl AM.
    Chemotherapy; 1992 May 01; 38(5):324-9. PubMed ID: 1286574
    [Abstract] [Full Text] [Related]

  • 37. Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
    Urban C, Mariano N, Mosinka-Snipas K, Wadee C, Chahrour T, Rahal JJ.
    J Antimicrob Chemother; 1996 Feb 01; 37(2):361-4. PubMed ID: 8707748
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R, Noriega ER, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2015 Dec 15; 14():53. PubMed ID: 26667651
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.